Tan TJ, Sammons S, Im YH, She L, et al. Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer. Clin Cancer Res 2024 Jan 18. doi: 10.1158/1078-0432.CCR-23-2513.
PMID: 38236575